1Ohta M, Tarnawski AS, Itani R et al. Tumor necrosis factor alpha regulates nitric oxide synthase expression in portal hypertensive gastric mucosa of rats. Hepatology, 1998,27 (4) : 906.
2Wang JY, Hsieh JS, Huang TJ. The effect of portal hypertension on transforming growth factor-alpha and epidermal growth factor receptor in the gastric mucosa of rats. Int Surg,1998,83(3):220.
3Gandhi CR, Kuddus RH, Nemoto EM et al. Endotoxin treatment causes an upregulation of the endothelin system in the liver amelioration of increased portal resistance by endothelin receptor antagonism. J Gastroenterol Hepatol, 2001,6 (1) ~ 61.
4Chang D, Levine MS, Ginsberg GG et al. Portal hypertensive gastropathy:radiographic findings in eight patients. AJR Am J Roentgenol, 2000,175 (6) : 1609.
5Zhou Y, Qiao L,Wu Jet al. Comparison of the efficacy of octreotide, vasopressin, and omeprazole in the control of acute bleeding in patients with portal hypertensive gastropathy:A controlled study. J Gastroenterol Hepatol,2002,17(9) :973.
6Nomura H, Miyake K, Hirakata R et al. Rebamipide prevents occurrence of gastric lesions following transcatheter arterial embolization in the hepatic artery. J Gastroenterol Hepatol, 1999, 14(5) :495.
7Munoz J, Albillos A, Perez-Paramo Met al. Factors mediating the hemodynamic effects of tumor necrosis factor-alpha in portal hypertensive rats. Am J Physiol, 1999,276 : 687.
